DTX2
gene geneOn this page
Also known as RNF58KIAA1528
Summary
DTX2 (deltex E3 ubiquitin ligase 2, HGNC:15973) is a protein-coding gene on chromosome 7q11.23, encoding Probable E3 ubiquitin-protein ligase DTX2 (Q86UW9). Regulator of Notch signaling, a signaling pathway involved in cell-cell communications that regulates a broad spectrum of cell-fate determinations.
DTX2 functions as an E3 ubiquitin ligase (Takeyama et al., 2003 [PubMed 12670957]).
Source: NCBI Gene 113878 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 140 total
- MANE Select transcript:
NM_001102594
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15973 |
| Approved symbol | DTX2 |
| Name | deltex E3 ubiquitin ligase 2 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RNF58, KIAA1528 |
| Ensembl gene | ENSG00000091073 |
| Ensembl biotype | protein_coding |
| OMIM | 613141 |
| Entrez | 113878 |
Gene structure
Transcript identifiers
Ensembl transcripts: 48 — 41 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000324432, ENST00000413936, ENST00000423646, ENST00000425780, ENST00000429179, ENST00000430490, ENST00000435251, ENST00000435861, ENST00000438930, ENST00000442516, ENST00000446600, ENST00000446820, ENST00000451769, ENST00000456590, ENST00000457529, ENST00000465488, ENST00000467729, ENST00000468546, ENST00000472426, ENST00000479915, ENST00000492339, ENST00000899001, ENST00000899002, ENST00000899003, ENST00000899004, ENST00000899005, ENST00000899006, ENST00000899007, ENST00000899008, ENST00000899009, ENST00000899010, ENST00000899011, ENST00000899012, ENST00000899013, ENST00000899014, ENST00000899015, ENST00000899016, ENST00000899017, ENST00000899018, ENST00000920551, ENST00000920552, ENST00000920553, ENST00000920554, ENST00000944733, ENST00000944734, ENST00000944735, ENST00000944736, ENST00000944737
RefSeq mRNA: 4 — MANE Select: NM_001102594
NM_001102594, NM_001102595, NM_001102596, NM_020892
CCDS: CCDS43605, CCDS5587
Canonical transcript exons
ENST00000430490 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000369924 | 76497337 | 76497477 |
| ENSE00001146263 | 76463545 | 76463709 |
| ENSE00001755686 | 76461709 | 76461836 |
| ENSE00002721179 | 76492153 | 76492253 |
| ENSE00003459592 | 76500441 | 76500520 |
| ENSE00003536826 | 76502298 | 76502456 |
| ENSE00003572603 | 76482508 | 76483147 |
| ENSE00003578695 | 76505374 | 76505991 |
| ENSE00003639247 | 76480421 | 76480777 |
| ENSE00003658954 | 76504356 | 76504445 |
| ENSE00003679979 | 76503426 | 76503587 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.06.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.06 | gold quality |
| esophagus mucosa | UBERON:0002469 | 95.59 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.83 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.40 | gold quality |
| sural nerve | UBERON:0015488 | 94.04 | gold quality |
| right testis | UBERON:0004534 | 93.99 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.59 | gold quality |
| left testis | UBERON:0004533 | 93.55 | gold quality |
| blood | UBERON:0000178 | 93.31 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 92.98 | gold quality |
| testis | UBERON:0000473 | 92.62 | gold quality |
| skin of leg | UBERON:0001511 | 92.22 | gold quality |
| zone of skin | UBERON:0000014 | 92.13 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.90 | gold quality |
| vagina | UBERON:0000996 | 91.51 | gold quality |
| right uterine tube | UBERON:0001302 | 91.12 | gold quality |
| esophagus | UBERON:0001043 | 90.27 | gold quality |
| granulocyte | CL:0000094 | 90.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.85 | gold quality |
| transverse colon | UBERON:0001157 | 89.04 | gold quality |
| tonsil | UBERON:0002372 | 89.04 | gold quality |
| prostate gland | UBERON:0002367 | 89.01 | gold quality |
| spleen | UBERON:0002106 | 88.92 | gold quality |
| uterine cervix | UBERON:0000002 | 88.33 | gold quality |
| ectocervix | UBERON:0012249 | 87.88 | gold quality |
| body of stomach | UBERON:0001161 | 87.57 | gold quality |
| fundus of stomach | UBERON:0001160 | 87.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 87.29 | gold quality |
| endocervix | UBERON:0000458 | 87.03 | gold quality |
| stomach | UBERON:0000945 | 87.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.97 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting DTX2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-202-3P | 99.84 | 71.41 | 1290 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-3194-5P | 96.80 | 64.90 | 1027 |
| HSA-MIR-3943 | 95.87 | 64.57 | 523 |
Literature-anchored findings (GeneRIF, showing 3)
- It is reported that BBAP and the human family of DTX proteins (DTX1, DTX2, and DTX3) function as E3 ligases based on their capacity for self-ubiquitination. (PMID:12670957)
- DTX2 is a gene encoding a WWE-RING-finger protein and involved in regulating heart development and heart functions. (PMID:17286044)
- [DTX2 overexpression promotes migration and invasion of colorectal cancer cells through the Notch2/Akt axis]. (PMID:37087577)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dtx2 | ENSDARG00000032933 |
| mus_musculus | Dtx2 | ENSMUSG00000004947 |
| rattus_norvegicus | Dtx2 | ENSRNOG00000001432 |
Paralogs (4): DTX4 (ENSG00000110042), DTX1 (ENSG00000135144), DTX3L (ENSG00000163840), DTX3 (ENSG00000178498)
Protein
Protein identifiers
Probable E3 ubiquitin-protein ligase DTX2 — Q86UW9 (reviewed: Q86UW9)
Alternative names: Protein deltex-2, RING finger protein 58, RING-type E3 ubiquitin transferase DTX2
All UniProt accessions (11): Q86UW9, C9IYX1, C9JEH4, C9JF39, C9JII1, C9JLU8, C9JS11, C9JVC8, C9JY61, E7ET89, H7C3B8
UniProt curated annotations — full annotation on UniProt →
Function. Regulator of Notch signaling, a signaling pathway involved in cell-cell communications that regulates a broad spectrum of cell-fate determinations. Probably acts both as a positive and negative regulator of Notch, depending on the developmental and cell context. Mediates the antineural activity of Notch, possibly by inhibiting the transcriptional activation mediated by MATCH1. Functions as a ubiquitin ligase protein in vitro, suggesting that it may regulate the Notch pathway via some ubiquitin ligase activity.
Subunit / interactions. Homodimer. May form a heterodimer with other members of the Deltex family. Interacts with NOTCH1.
Subcellular location. Cytoplasm. Nucleus.
Domain organisation. The WWE domains are thought to mediate some protein-protein interaction, and are frequently found in ubiquitin ligases.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the Deltex family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86UW9-1 | 1, A | yes |
| Q86UW9-2 | 2, B |
RefSeq proteins (4): NP_001096064, NP_001096065, NP_001096066, NP_065943 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001841 | Znf_RING | Domain |
| IPR004170 | WWE_dom | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR018123 | WWE-dom_subgr | Domain |
| IPR037197 | WWE_dom_sf | Homologous_superfamily |
| IPR039396 | Deltex_C | Domain |
| IPR039398 | Deltex_fam | Family |
| IPR039399 | Deltex_C_sf | Homologous_superfamily |
Pfam: PF02825, PF18102
UniProt features (45 total): strand 13, turn 8, modified residue 6, helix 5, sequence variant 3, compositionally biased region 3, domain 2, region of interest 2, chain 1, splice variant 1, zinc finger region 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6Y2X | X-RAY DIFFRACTION | 1.77 |
| 6Y22 | X-RAY DIFFRACTION | 2.07 |
| 6Y3J | X-RAY DIFFRACTION | 2.6 |
| 6IR0 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86UW9-F1 | 73.01 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 215, 233, 249, 256, 360, 213
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus |
MSigDB gene sets: 165 (showing top):
REACTOME_SIGNALING_BY_NOTCH, AP1_01, TGCGCANK_UNKNOWN, TAL1ALPHAE47_01, TGCTGAY_UNKNOWN, BACH2_01, TGANTCA_AP1_C, SHIN_B_CELL_LYMPHOMA_CLUSTER_2, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, NRF2_Q4, NRF2_01, chr7q11, NFE2_01, TAL1BETAE47_01, AP1FJ_Q2
GO Biological Process (2): Notch signaling pathway (GO:0007219), protein ubiquitination (GO:0016567)
GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO Cellular Component (4): nucleoplasm (GO:0005654), cytoplasm (GO:0005737), nuclear membrane (GO:0031965), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Signaling by NOTCH1 | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cell surface receptor signaling pathway | 1 |
| protein modification by small protein conjugation | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
560 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DTX2 | RFX6 | Q8HWS3 | 865 |
| DTX2 | SS18L1 | O75177 | 746 |
| DTX2 | RFX3 | P48380 | 731 |
| DTX2 | CCNK | O75909 | 720 |
| DTX2 | ANK2 | Q01484 | 713 |
| DTX2 | ANK1 | P16157 | 709 |
| DTX2 | ANK3 | Q12955 | 709 |
| DTX2 | RFX2 | P48378 | 581 |
| DTX2 | RFX4 | Q33E94 | 549 |
| DTX2 | NEUROG3 | Q9Y4Z2 | 548 |
| DTX2 | VPS9D1 | Q9Y2B5 | 500 |
| DTX2 | PPY | P01298 | 498 |
| DTX2 | OBSL1 | O75147 | 437 |
| DTX2 | RNF146 | Q9NTX7 | 417 |
| DTX2 | DDX39A | O00148 | 401 |
IntAct
507 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DTX2 | UBE2D4 | psi-mi:“MI:0915”(physical association) | 0.880 |
| UBE2D4 | DTX2 | psi-mi:“MI:0915”(physical association) | 0.880 |
| DTX2 | NCS1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| DTX2 | ALKBH4 | psi-mi:“MI:0915”(physical association) | 0.830 |
| ALKBH4 | DTX2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| NCS1 | DTX2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| DTX2 | NCALD | psi-mi:“MI:0915”(physical association) | 0.800 |
| NCALD | DTX2 | psi-mi:“MI:0915”(physical association) | 0.800 |
BioGRID (435): DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid), DTX2 (Two-hybrid)
ESM2 similar proteins: A0A5F9C6I2, A2BDA5, A4IG66, A4IIM9, A9ZLX4, D3ZXK7, O00750, O14525, O15105, O15169, O15259, O15360, O35253, O54828, O70240, O88406, O88566, P49805, Q1JPG0, Q3B7M3, Q3SZD5, Q5JV73, Q5T011, Q5XJS0, Q5XPI3, Q61137, Q62925, Q66K64, Q6AYG1, Q6P1H6, Q6P2E9, Q6PFH3, Q7L4E1, Q7TP65, Q86UW9, Q86XL3, Q8BK03, Q8CDG3, Q8CF97, Q8N9B5
Diamond homologs: A1D3C5, A2A5Z6, A2QQ28, A9JRZ0, B0XQ72, B4F6W9, B8N7E5, C6KTB7, E1B7Q7, F1LP64, F1RCR6, G5E870, O00308, O13834, O14326, O15033, P33202, P40985, Q0CCL1, Q14669, Q15386, Q2TAS2, Q2UBP1, Q4WTF3, Q5BDP1, Q61010, Q6PDK8, Q757T0, Q80U95, Q86UW9, Q86Y01, Q8AW93, Q8BZZ3, Q8C863, Q8CHG5, Q8R3P2, Q96J02, Q9DBH0, Q9H0M0, Q9HAU4
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | DTX2 | ubiquitination |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 51 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Antigen processing: Ubiquitination & Proteasome degradation | 5 | 7.8× | 9e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| regulation of signal transduction | 6 | 36.5× | 3e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
140 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 108 |
| Likely benign | 13 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2545 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:76477079:G:GT | donor_gain | 1.0000 |
| 7:76480775:CCGG:C | donor_loss | 1.0000 |
| 7:76480776:CGGT:C | donor_loss | 1.0000 |
| 7:76480777:GGTA:G | donor_loss | 1.0000 |
| 7:76480778:G:GC | donor_loss | 1.0000 |
| 7:76480779:T:G | donor_loss | 1.0000 |
| 7:76482506:A:AG | acceptor_gain | 1.0000 |
| 7:76482506:AG:A | acceptor_gain | 1.0000 |
| 7:76482507:G:GA | acceptor_gain | 1.0000 |
| 7:76482507:G:T | acceptor_loss | 1.0000 |
| 7:76482507:GG:G | acceptor_gain | 1.0000 |
| 7:76482507:GGC:G | acceptor_gain | 1.0000 |
| 7:76482507:GGCA:G | acceptor_gain | 1.0000 |
| 7:76482507:GGCAC:G | acceptor_gain | 1.0000 |
| 7:76492151:A:AG | acceptor_gain | 1.0000 |
| 7:76492152:G:GG | acceptor_gain | 1.0000 |
| 7:76502296:A:AG | acceptor_gain | 1.0000 |
| 7:76502297:G:GG | acceptor_gain | 1.0000 |
| 7:76502449:GCAA:G | donor_gain | 1.0000 |
| 7:76503585:CAGG:C | donor_loss | 1.0000 |
| 7:76503588:GTGAG:G | donor_loss | 1.0000 |
| 7:76504350:CCGCA:C | acceptor_loss | 1.0000 |
| 7:76504351:CGCAG:C | acceptor_loss | 1.0000 |
| 7:76504352:GCA:G | acceptor_loss | 1.0000 |
| 7:76504353:CAGG:C | acceptor_loss | 1.0000 |
| 7:76504354:A:AG | acceptor_gain | 1.0000 |
| 7:76504354:A:G | acceptor_loss | 1.0000 |
| 7:76504354:AG:A | acceptor_gain | 1.0000 |
| 7:76504355:G:GG | acceptor_gain | 1.0000 |
| 7:76504355:GG:G | acceptor_gain | 1.0000 |
AlphaMissense
4046 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:76502301:T:C | C412R | 1.000 |
| 7:76502303:C:G | C412W | 1.000 |
| 7:76502424:T:C | C453R | 1.000 |
| 7:76502426:C:G | C453W | 1.000 |
| 7:76503441:T:A | C469S | 1.000 |
| 7:76503441:T:C | C469R | 1.000 |
| 7:76503442:G:C | C469S | 1.000 |
| 7:76504401:T:C | F533L | 1.000 |
| 7:76504403:T:A | F533L | 1.000 |
| 7:76504403:T:G | F533L | 1.000 |
| 7:76504420:T:C | L539P | 1.000 |
| 7:76505411:T:C | L560P | 1.000 |
| 7:76505416:T:C | F562L | 1.000 |
| 7:76505417:T:C | F562S | 1.000 |
| 7:76505418:C:A | F562L | 1.000 |
| 7:76505418:C:G | F562L | 1.000 |
| 7:76505464:T:A | W578R | 1.000 |
| 7:76505464:T:C | W578R | 1.000 |
| 7:76505466:G:C | W578C | 1.000 |
| 7:76505466:G:T | W578C | 1.000 |
| 7:76505484:G:C | K584N | 1.000 |
| 7:76505484:G:T | K584N | 1.000 |
| 7:76505558:T:C | L609P | 1.000 |
| 7:76480573:T:A | W22R | 0.999 |
| 7:76480573:T:C | W22R | 0.999 |
| 7:76480575:G:C | W22C | 0.999 |
| 7:76480575:G:T | W22C | 0.999 |
| 7:76480739:T:A | I77N | 0.999 |
| 7:76502302:G:A | C412Y | 0.999 |
| 7:76502302:G:T | C412F | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000130029 (7:76483793 C>T), RS1000325454 (7:76465079 C>G), RS1000603294 (7:76483583 G>A,C), RS1000930599 (7:76469032 T>G), RS1000978791 (7:76479403 A>C,G), RS1001010088 (7:76478670 C>A), RS1001169189 (7:76489981 C>G,T), RS1001256708 (7:76469559 A>C), RS1001357618 (7:76503300 G>A,T), RS1001536844 (7:76490978 G>A,C), RS1001812967 (7:76478434 G>A,T), RS1001858343 (7:76472576 C>A,G), RS1001924934 (7:76472102 A>G), RS1001986349 (7:76480863 G>A,C), RS1002141144 (7:76495436 T>A,C)
Disease associations
OMIM: gene MIM:613141 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance | 2 |
| Air Pollutants | affects expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| aflatoxin B2 | affects methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| enzalutamide | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
4 cell lines: 3 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D7NV | Ubigene A-549 DTX2 KO | Cancer cell line | Male |
| CVCL_D8KA | Ubigene HCT 116 DTX2 KO | Cancer cell line | Male |
| CVCL_D9DM | Ubigene HEK293 DTX2 KO | Transformed cell line | Female |
| CVCL_E0BV | Ubigene HeLa DTX2 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.